Ziprasidone hydrochloride vs. Vistaril: side effect and effectiveness comparison - a phase IV clinical study
Summary:
We compare the side effects and drug effectiveness of Ziprasidone hydrochloride and Vistaril. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 95,469 people who take Ziprasidone hydrochloride and Vistaril, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
95,469 people who take Ziprasidone hydrochloride and Vistaril are studied.
What is Ziprasidone hydrochloride?
Ziprasidone hydrochloride has active ingredients of ziprasidone hydrochloride. It is often used in bipolar disorder. eHealthMe is studying from 1,558 Ziprasidone hydrochloride users for its effectiveness, alternative drugs and more.
What is Vistaril?
Vistaril has active ingredients of hydroxyzine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 9,040 Vistaril users for its effectiveness, alternative drugs and more.
Number of reports submitted per year:
Drugs being compared in this study:
- Vistaril (hydroxyzine hydrochloride)
- Ziprasidone Hydrochloride (ziprasidone hydrochloride)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Ziprasidone Hydrochloride:
- not at all: 12.98 %
- somewhat: 19.95 %
- moderate: 29.92 %
- high: 23.77 %
- very high: 13.39 %
Vistaril:
- not at all: 5.5600000000000005 %
- somewhat: 29.22 %
- moderate: 35.24 %
- high: 20.2 %
- very high: 9.77 %
Want to compare Ziprasidone hydrochloride with Vistaril?
Personalize this study to your gender and age (0-99+).How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Ate? ?, Arikan MF, Kaplan M, Altay M, "Hydroxyzine induced pancytopenia and petechial rashes: a rare complication", Journal Of Contemporary Medicine, 2017 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Ziprasidone hydrochloride (1,470 reports)
- Vistaril (8,143 reports)
Common Ziprasidone hydrochloride side effects:
- Drug ineffective: 505 reports
- Erection problems: 398 reports
- Movement - uncontrolled or slow: 394 reports
- Disturbance in social behavior: 342 reports
- Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 184 reports
Browse all side effects of Ziprasidone hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Vistaril side effects:
- Stress and anxiety: 730 reports
- Pain: 665 reports
- Fatigue (feeling of tiredness): 655 reports
- Headache (pain in head): 574 reports
- Depression: 540 reports
- Insomnia (sleeplessness): 491 reports
Browse all side effects of Vistaril:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on ziprasidone hydrochloride and hydroxyzine hydrochloride (the active ingredients of Ziprasidone hydrochloride and Vistaril, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lisinopril and Corynebacterium Infection - now
- Methergine and Birth Control - now
- Euthyrox and Dyslipidaemia - a second ago
- Bumex and Aldactone drug interaction - 4 seconds ago
- Saizen and Growth Retardation - 5 seconds ago
- Metformin and Otitis Externa - 7 seconds ago
- Cefotaxime and Influenza B Virus Test Positive - 8 seconds ago
- Erlotinib Hydrochloride and Pain Of Skin - 16 seconds ago
- Foradil and Stress And Anxiety - 24 seconds ago
- Nicorette and Extrapyramidal Disorder - 37 seconds ago